This study evaluates the feasibility of using high intensity focused ultrasound (HIFU) for the treatment of liver alveococcosis. HIFU ablation was carried out in 36 patients with alveococcosis of the liver. The median age of patients was 39.24±12, 93 years (range: 20-66 years). The efficiency of treatment was monitored in real time with morphological evaluation, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound (US), and with morphological cytological and electron microscopy studies. HIFU ablation has shown effectiveness in destroying the protoscolexes, laminar and cell elements of the cuticular and germinal membrane of the alveococcosis larvocyst, causing the death of the cells of initial metamorphosis of alveococcosis, which is responsible for the dissemination of the parasite in the liver. Therefore HIFU-therapy is a promising and effective treatment for liver alveococcosis.
This study evaluates the feasibility of using high intensity focused ultrasound (HIFU) for the treatment of hydatid cysts of the liver. HIFU ablation was carried out in 62 patients with echinococcosis of the liver. The mean age of patients was 40.76±14.84 (range: 17-72 years). The effectiveness of the treatment was monitored in real-time by changes in the gray-scale, and by morphological studies, computed tomography, magnetic resonance imaging, and ultrasound. Criteria for evaluating the effectiveness of treatment in real time were outlines. Cytomorphological picture of destructive changes of parasitic elements was presented as well. Loss of embryonic elements of the parasite was observed at the subcellular level after HIFU-ablation and underlines the effectiveness of HIFU.
The main method of treatment of breast fibroadenomas, until recently, was considered a surgical. However, there is research the authors of a new non-invasive method of treatment HIFU. The paper describes the mechanism of action and clinical features of the effect of treatment of fibroadenomas of the mammary glands by HIFU. Morрhocytology effects confirmation of the method HIFU ablation breast fibroadenoma.
Objectives: The aim of this study was to evaluate the kidney allograft after transplant to assess restoration of blood flow, the time required to functionally recovery after surgery, and the ability to differentiate normal from pathologic grafts using color Doppler ultrasonography in the early posttransplant period. Materials and Methods: Sixteen kidney recipients underwent renal color Doppler ultrasonography examinations 1, 2, 3, 7, 15, and 30 days after transplant. We evaluated the clinical and biochemical test results of recipients and the functioning allografts and evaluated the acute pathology. Results of resistive index in color Doppler ultrasonography were compared with blood test results. Results: During the early postoperative period after kidney transplant, the average size of the kidney was 10.7 × 5.1 cm, with parenchyma at 1.7 cm. The structure of the parenchyma was nonhomogeneous in 14 patients and homogeneous in 2 patients. The medullary pyramid layer was prominent in 6 patients, moderately prominent in 7 patients, and not prominent in 3 patients. The pyelocaliceal system was condensed in 1 patient. Hematoma in the perinephrium was found in 5 patients, and free fluid was found in 5 patients. Satisfactory vascularization of allografts occurred in 14 patients, with resistive index sensitivity of 93% and specificity of 83%.
Conclusions:Color Doppler ultrasonography and resistive index results were useful in evaluating kidney allografts during the early postoperative period and in confirming their condition despite excessive blood parameter values.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.